Literature DB >> 2722429

Studies on bioavailability of oral biotin doses for humans.

R Bitsch1, I Salz, D Hötzel.   

Abstract

Single biotin doses (600 micrograms and 900 micrograms) orally administered to male and female volunteers were very rapidly eliminated from plasma after absorption leading to a remarkable increase of urinary excretion. A prolonged enhancement of plasma levels occurred only after continuous supplementation with 300 micrograms biotin/day for 1 week and following 900 micrograms biotin/day for another week. From the diurnal turnover of the plasma level after oral stimulation with 600 micrograms biotin some biokinetic indices, such as the constants of invasion and elimination rate as well as the elimination half life time were determined. The median of the invasion constant was calculated to 2.068 h-1, that one of elimination constant to 0.3867 h-1 suggesting no indication of diminished body stores. The elimination half life time of the administered biotin dose from plasma amounted to 1 hour, 50 minutes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722429

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  3 in total

1.  HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYS.

Authors:  Alissa Minkovsky; Mark N Lee; Mitra Dowlatshahi; Trevor E Angell; Lilian S Mahrokhian; Athena K Petrides; Stacy E F Melanson; Ellen Marqusee; Whitney W Woodmansee
Journal:  AACE Clin Case Rep       Date:  2016

2.  Clinical Presentation and Positive Outcome of Two Siblings with Holocarboxylase Synthetase Deficiency Caused by a Homozygous L216R Mutation.

Authors:  T P Slavin; S J Zaidi; C Neal; B Nishikawa; L H Seaver
Journal:  JIMD Rep       Date:  2013-09-13

3.  Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults.

Authors:  Danni Li; Angela Radulescu; Rupendra T Shrestha; Matthew Root; Amy B Karger; Anthony A Killeen; James S Hodges; Shu-Ling Fan; Angela Ferguson; Uttam Garg; Lori J Sokoll; Lynn A Burmeister
Journal:  JAMA       Date:  2017-09-26       Impact factor: 56.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.